Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults

被引：0
|
作者：
Tu, Sanfang [1 ]
Zhou, Lijuan [1 ]
Huang, Rui [1 ]
Zhou, Xuan [1 ]
Yang, Jilong [1 ]
Li, Meifang [1 ]
Jin, Bo [1 ]
Wang, Langqi [1 ]
Zhuo, Yaqi [1 ]
Chen, Huifang [1 ]
Chang, Lung-Ji [2 ,3 ]
Li, Yuhua [1 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Hematol, Guangzhou, Peoples R China
[2] Univ Elect Sci & Technol China, Sch Med, Chengdu, Peoples R China
[3] Geno Immue Med Inst, Shenzhen, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186622
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy and Safety of Chimeric Antigen Receptor T Cells Targeting CD19 in Autoimmune Diseases
    Nicoletti, Simon
    HEMATOLOGIE, 2024, 30 (02): : 96 - 98
  • [32] Prevention of immune escape from chimeric antigen receptor T cells by loss of antigen expression in BCD19+ acute lymphoblastic leukemia via a CD19 and CD22 receptor co-targeting approach
    Nicoletti, Simon
    HEMATOLOGIE, 2024, 30 (01): : 15 - 17
  • [33] Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Heng, Gang
    Jia, Jiankun
    Li, Shiqi
    Fu, Gang
    Wang, Meiling
    Qin, Dabing
    Li, Yunyan
    Pei, Li
    Tian, Xiaobo
    Zhang, Jiasi
    Wu, Yi
    Xiang, Shali
    Wan, Jia
    Zhu, Wei
    Zhang, Pei
    Zhang, Qianzhen
    Peng, Xi
    Wang, Linling
    Wang, Ping
    Wei, Zhihao
    Zhang, Yingzi
    Wang, Guiqin
    Chen, Xue
    Zhang, Chengcheng
    Sun, Yanni
    Zhao, Wenxu
    Fan, Yahan
    Yang, Zhi
    Chen, Jieping
    Qian, Cheng
    CLINICAL CANCER RESEARCH, 2020, 26 (07) : 1606 - 1615
  • [34] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS TARGETING THE CD19 ANTIGEN FOR THE TREATMENT OF RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
    Curran, Kevin
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
  • [35] Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/ refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Toren, Amos
    Shouval, Roni
    Itzhaki, Orit
    Avigdor, Abraham
    Shimoni, Avichai
    Nagler, Arnon
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (04)
  • [36] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    BLOOD, 2019, 134
  • [37] CD19 CAR T cells for adults with relapsed or refractory acute lymphoblastic leukaemia
    Maus, Marcela V.
    LANCET, 2021, 398 (10299): : 466 - 467
  • [38] Determination of the effect of target site density on the efficacy of CD22 chimeric antigen receptor t-cell therapy to treat acute lymphoblastic leukemia.
    Sang Nguyen
    Majzner, Robbie G.
    Chien, Christopher
    Qin, Haiying
    Fry, Terry
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Safety and Efficacy of CD19 Chimeric Antigen Receptor-Modified T Cells for Relapsed/Refractory Acute Lymphocytic Leukemia Under Fludarabine and Cyclophosphamide based Lymphodepletion
    Hu, Y.
    Wu, Z.
    Luo, Y.
    Shi, J.
    Pu, C.
    Wei, G.
    Sun, J.
    Yu, J.
    Xiao, L.
    Huang, H.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S99 - S100
  • [40] CD19/CD22 Chimeric Antigen Receptor T Cell Cocktail Therapy following Autologous Transplantation in Patients with Relapsed/Refractory Aggressive B Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Huang, Liang
    Hong, Zhenya
    Meng, Li
    Zhou, Xiaoxi
    Wang, Jue
    Yang, Yang
    Xu, Hao
    Zhang, Shangkun
    Xiao, Min
    Chen, Liting
    Zheng, Miao
    Li, Chunrui
    Mao, Xia
    Gu, Chaojiang
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 910.e1 - 910.e11
12345